Abstract
Bronchial asthma is one of the most common chronic conditions in pediatric practice, with increasing prevalence hampered by poor socioeconomic impacts, leading to major public health issues. Considered as a complex heterogeneous syndrome, not a single disease, the management of the disease is a real challenge, impacting medical staff, patients and caregivers. Over the decades, a significant number of diagnostic and treatment regimen have been developed to achieve good standards, sustaining balanced control of the disease. This paper attempts a review on the establishment of new trends in the management of bronchial asthma in the pediatric age group.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference69 articles.
1. European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years;Gaillard;Eur. Respir. J.,2021
2. Pediatric asthma: An unmet need for more effective, focused treatments;Papadopoulos;Pediatr. Allergy Immunol.,2019
3. New approach in the treatment pf children with asthma;Pediatr. Integral,2021
4. Epidemiology of Asthma in Children and Adults;Dharmage;Front. Pediatr.,2019
5. Challenges and choices in the pharmacological treatment of non-severe pediatric asthma: A commentary for the practicing physician;Kalayci;World Allergy Organ. J.,2019
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献